Variables | HR | 95% CI | p Value |
---|---|---|---|
MACE | <0.001 | ||
Age | 0.958 | 0.921 to 0.999 | 0.043 |
Gender; male/female | 1.235 | 0.545 to 2.722 | 0.604 |
LV fibrosis mass; high/low | 2.198 | 0.669 to 10.327 | 0.210 |
Localisation score; high/low | 20.487 | 3.504 to 398.919 | <0.001 |
VA events | <0.001 | ||
Age | 0.987 | 0.946 to 1.035 | 0.580 |
Gender; male/female | 1.525 | 0.620 to 3.685 | 0.350 |
LV fibrosis mass; high/low | 1.308 | 0.395 to 6.098 | 0.685 |
Localisation score; high/low | 14.546 | 2.579 to 276.708 | <0.001 |
MACE, major adverse cardiac events; VA, ventricular tachyarrhythmias.